More Stories

Informist, Monday, Oct. 6, 2025

MUMBAI – Aster DM Healthcare Ltd. Monday said it has received letters of no objection with "no adverse observations" from BSE Ltd. and the National Stock Exchange of India Ltd. in connection with the proposed scheme of merger of Quality Care India Ltd. with the company. The scheme will remain subject to other statutory and regulatory approvals, including the approval of the respective shareholders and creditors of the companies involved, Aster DM Healthcare said in an exchange filing.

In this regard, the Securities and Exchange Board of India, in a letter Monday, said the company shall disclose all details of ongoing adjudication and recovery proceedings, prosecution initiated, and all other enforcement actions, if any, against it, its promoters, and its directors, before the National Company Law Tribunal and shareholders while seeking approval for the scheme. The company shall also ensure that additional information, if any, submitted by the company after filing the scheme with the stock exchanges, from the date of receipt of the letter, is displayed on the websites of the listed company and the stock exchanges.

Further, SEBI said the company shall ensure that the financials in the scheme, including financials considered for the valuation report, are not for a period more than six months ago. The company was advised that the details of the proposed scheme under consideration as provided to the stock exchanges should be prominently disclosed in the notice sent to shareholders. It was also advised that the proposed equity shares, if any, to be issued in terms of the "scheme" shall be in dematerialised form only.

In April, the Competition Commission of India had approved the proposed merger of Quality Care India with Aster DM Healthcare. In November 2024, the company's board had approved its merger with Blackstone- and TPG-backed Quality Care India. The amalgamated unit of Aster DM Healthcare and Quality Care will be called Aster DM Quality Care Ltd. and will have a combined portfolio of Aster DM Healthcare, CARE Hospitals, KIMSHEALTH, and Evercare.

Aster DM Healthcare had reported a consolidated net profit of INR 855.20 million for the June quarter on a revenue of INR 10.78 billion. Monday, shares of the company closed 4.2% higher at INR 672.55 on the National Stock Exchange.  End

Reported by Pooja Sawant

Edited by Rajeev Pai

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.

Informist Media Tel +91 (22) 6985-4000 

Send comments to feedback@informistmedia.com

© Informist Media Pvt. Ltd. 2025. All rights reserved.